KLH conjugated synthetic peptide selected from the C-terminal region of human UBTD1.
Human breast carcinoma tissue. 293 cell lysates transiently transfected with the UBTD1 gene.
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Protein A purified
ab63093 is purified through a protein A column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/100 - 1/500. Detects a band of approximately 30 kDa (predicted molecular weight: 26 kDa).
Contains 1 ubiquitin-like domain.
Information by UniProt
Ubiquitin domain containing 1 antibody
Ubiquitin domain containing protein 1 antibody
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UBTD1 antibody (ab63093)
ab63093 at 1/50 dilution, staining UBTD1 in human breast carcinoma by Immunohistochemistry using formalin-fixed, paraffin-embedded tissue. ab63093 was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
Western blot - Anti-UBTD1 antibody (ab63093)
All lanes :
Anti-UBTD1 antibody (ab63093) at 1/100 dilution
Lane 1 :
293 cell lysates, nontransfected
Lane 2 :
293 cell lysates, transiently transfected with the UBTD1 gene
Lysates/proteins at 2 µg per lane.
Predicted band size:
Observed band size:
30 kDa (
why is the actual band size different from the predicted?
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"